DEFA14A: Adaptive Biotechnologies Sets Date for Annual Shareholder Meeting, Outlines Key Proposals
Proxy Statement
Adaptive Biotechnologies Corporation will hold its annual shareholder meeting on June 7, 2024, to vote on director elections, executive compensation, and auditor ratification.
Summary
- Adaptive Biotechnologies Corporation will hold its annual meeting of shareholders on June 7, 2024.
- Shareholders of record as of April 10, 2024, are eligible to vote.
- The meeting will be held entirely via the internet.
- Key proposals include the election of two Class II director nominees, an advisory vote on executive compensation, and the ratification of Ernst & Young LLP as the independent auditor for the year ending December 31, 2024.
Sentiment
Score: 7
Explanation: The document is a routine proxy statement, indicating standard corporate governance procedures. The sentiment is neutral to slightly positive as it reflects the company's commitment to shareholder engagement.
Positives
- Shareholders have the opportunity to participate in the company's governance by voting on key proposals.
- The company is providing multiple avenues for shareholders to access proxy materials and vote, including online, by phone, and by mail.
Future Outlook
The proxy statement outlines matters for shareholder voting, which will influence the company's governance and financial oversight.
Industry Context
This announcement is a standard part of corporate governance, ensuring shareholders have a voice in key decisions.
Stakeholder Impact
- Shareholders will have the opportunity to influence the company's direction through their votes.
- The outcome of the votes will impact the composition of the board of directors and the selection of the company's auditor.
Next Steps
- Shareholders should review the proxy materials and vote on the proposals.
- The company will hold the annual meeting on June 7, 2024, and announce the results of the voting.
Key Dates
| Date | Description |
|---|---|
| April 10, 2024 | Shareholders of record date |
| May 28, 2024 | Deadline to request paper copies of proxy materials. |
| June 5, 2024 | Deadline to register to attend the meeting. |
| June 7, 2024 | Annual Meeting of Shareholders. |
| December 31, 2024 | End of fiscal year for which Ernst & Young LLP will be the independent auditor. |
| 2027 | Year that the term expires for the Class II director nominees if elected. |
Keywords
shareholders, proxy statement, annual meeting, directors, executive compensation, auditor, Adaptive Biotechnologies
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.